Rare diseases

Views & Analysis

Genetic testing hopes to speed up drug development in rare e...

When it comes to fighting rare diseases, the biggest barrier to overcome is often the lack of knowledge around the condition.

Views & Analysis

Understanding the impact of a rare disease – the Health Hero...

Episode one of Kantar’s Health Heroes podcast looks at caregiving challenges for Gaucher disease and how patient registries can help deliver new treatment innovations and better outcomes fo

AI in Pharma Marketing

Genetic engineeering concept with 3d rendering robotic hand editing dna helix

AI for rare diseases: putting tech to work for small populat...

With the 12th annual Rare Disease Day on the horizon, it’s a pertinent time to think about how one of the most exciting technological innovations of the last decade, artificial intelligence

Views & Analysis

The biggest challenges in rare disease drug development – and how the industry is fighting them

The biggest challenges facing rare disease pharma – and how ...

As Rare Disease day 2020 approaches, we take a look at the biggest challenges facing orphan drug developers and ask whether the future is bright or bleak for these difficult conditions.

News

Podcast series to spotlight health heroes launched by Kantar

A new pharmaceutical podcast putting health heroes in the spotlight debuts in the runup to Rare Diseases Day 2020 with an instalment focusing on Gaucher disease.

Events